Novel Human C3 Derivatives for Therapeutic Complement Depletion
Complement depletion as a novel therapeutic approach, with applications in treating diseases with complement pathology.
Published: 29th July 2019

Patents
- Granted US Patent (8,632,780) and Japan 6488376. Other applications pending.
IP Status
- Patented
- Patent application submitted
Seeking
- Licensing
- Commercial partner
- Development partner
- Seeking investment